BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17196637)

  • 1. Morphine analgesic tolerance in 129P3/J and 129S6/SvEv mice.
    Bryant CD; Roberts KW; Byun JS; Fanselow MS; Evans CJ
    Pharmacol Biochem Behav; 2006 Dec; 85(4):769-79. PubMed ID: 17196637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMDA receptor antagonism disrupts the development of morphine analgesic tolerance in male, but not female C57BL/6J mice.
    Bryant CD; Eitan S; Sinchak K; Fanselow MS; Evans CJ
    Am J Physiol Regul Integr Comp Physiol; 2006 Aug; 291(2):R315-26. PubMed ID: 16601258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist.
    Kolesnikov Y; Pasternak GW
    J Pharmacol Exp Ther; 1999 Jul; 290(1):247-52. PubMed ID: 10381783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
    Juni A; Klein G; Kest B
    Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of effects of processed Aconiti tuber, U50488H and MK-801 on the antinociceptive tolerance to morphine.
    Shu H; Hayashida M; Huang W; An K; Chiba S; Hanaoka K; Arita H
    J Ethnopharmacol; 2008 Apr; 117(1):158-65. PubMed ID: 18328652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of NMDA receptor channel blockers, dizocilpine and memantine, on the development of opiate analgesic tolerance induced by repeated morphine exposures or social defeats in mice.
    Belozertseva IV; Bespalov AYu
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):270-4. PubMed ID: 9750014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of the potent D-amino acid oxidase inhibitor CBIO with morphine in pain and tolerance to analgesia.
    Gong N; Wang YC; Wang HL; Ma AN; Hashimoto K; Wang YX
    Neuropharmacology; 2012 Sep; 63(3):460-8. PubMed ID: 22587944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in morphine analgesic tolerance: a survey of 11 inbred mouse strains.
    Kest B; Hopkins E; Palmese CA; Adler M; Mogil JS
    Pharmacol Biochem Behav; 2002 Nov; 73(4):821-8. PubMed ID: 12213527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of systemic, intracerebral, or intrathecal administration of an N-methyl-D-aspartate receptor antagonist on associative morphine analgesic tolerance and hyperalgesia in rats.
    McNally GP; Westbrook RF
    Behav Neurosci; 1998 Aug; 112(4):966-78. PubMed ID: 9733203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically available NMDA antagonist, memantine, attenuates tolerance to analgesic effects of morphine in a mouse tail flick test.
    Popik P; Kozela E
    Pol J Pharmacol; 1999; 51(3):223-31. PubMed ID: 10600036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nociception increases during opioid infusion in opioid receptor triple knock-out mice.
    Juni A; Klein G; Pintar JE; Kest B
    Neuroscience; 2007 Jun; 147(2):439-44. PubMed ID: 17544222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive effect of combined application of magnesium and MK-801 on analgesic action of morphine.
    Bujalska-Zadrożny M; Duda K
    Pharmacology; 2014; 93(3-4):113-9. PubMed ID: 24577345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-methyl-D-aspartate receptor antagonist MK-801 suppresses glial pro-inflammatory cytokine expression in morphine-tolerant rats.
    Liu CH; Cherng CH; Lin SL; Yeh CC; Wu CT; Tai YH; Wong CS
    Pharmacol Biochem Behav; 2011 Sep; 99(3):371-80. PubMed ID: 21624390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in hyperalgesia during morphine infusion: effect of gonadectomy and estrogen treatment.
    Juni A; Klein G; Kowalczyk B; Ragnauth A; Kest B
    Neuropharmacology; 2008 Jun; 54(8):1264-70. PubMed ID: 18457849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614.
    Tiseo PJ; Inturrisi CE
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1090-6. PubMed ID: 8450453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of kappa opioid receptors in formalin-induced inhibition of analgesic tolerance to morphine in mice.
    Tokuyama S; Nagae R; Mashida E; Hamabe W
    J Pharm Pharmacol; 2007 Aug; 59(8):1109-15. PubMed ID: 17725853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are glycineB sites involved in the development of morphine tolerance?
    Kotlińska J
    Pol J Pharmacol; 2004; 56(1):51-7. PubMed ID: 15047977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia.
    Davis AM; Inturrisi CE
    J Pharmacol Exp Ther; 1999 May; 289(2):1048-53. PubMed ID: 10215686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
    Fischer BD; Carrigan KA; Dykstra LA
    J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
    Lutfy K; Doan P; Weber E
    Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.